A Proud Partner

RemTech is proud to partner with Goodwin Biotechnology, Inc. (‘GBI’) as it invests in its infrastructure and expands it capability in the biopharmaceutical market. GBI is a full-Service biopharmaceutical Contract Development and Manufacturing Organization (CDMO). RemTech provides Owner’s Project Management services and Quality and Compliance consultation services to GBI to assist in their continued success and growth in the biopharmaceutical market.

Shown in the picture from left to right:

Gunner Danielsen, Whiting-Turner; Design-Builder
Karl Pinto, GBI; Chairman of the Board of Directors
Darrin Shellin, GBI; Chief Executive Officer
Austin McDonald; RemTech LLC
TJ Bohne, Whiting-Turner; Design-Builder

Reaching Your Goal How RemTech Can Help You

Posted by Bob Matje

Robert “Bob” Matje, PE, CPIP, has held increasing levels of responsibility in several branded and generic pharmaceutical companies including general management. He has also lead reliability and maintenance, environmental, health and safety, automation, capital and qualification teams and served as the Serialization Project Management Office (PMO) Lead for Endo and for Pfizer, which included responsibility for establishing the serialization governance, scope development, schedule and cost. Bob is a member of the International Society of Pharmaceutical Engineering (ISPE) and was recently elected to his second term on ISPE’s International Board of Directors. Bob earned a BS in Engineering at Lafayette College and an MS in Engineering at Villanova University. He is a Registered Professional Engineer in Pennsylvania and was awarded his Certified Pharmaceutical Industry Professional certification in 2012.

Leave a Reply - Cancel reply